What is Sutro Biopharma's total assets?

Sutro Biopharma (STRO) reported total assets of $241.99M in Q1 2026.

How has Sutro Biopharma's total assets changed year-over-year?

Sutro Biopharma's total assets decreased by 24.7% year-over-year, from $321.43M to $241.99M.

What is the long-term trend for Sutro Biopharma's total assets?

Over 5 years (2020 to 2025), Sutro Biopharma's total assets has grown at a -15.1% compound annual growth rate (CAGR), from $394.11M to $173.83M.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Sutro Biopharma STRO Total Assets

Total Assets at other companies

PfizerPFE

$207.62B-0.2%

Gilead SciencesGILD

$56.28B-0.3%

RegenxbioRGNX

$341.89M-30.4%

Nuvectis Pharma, Inc.NVCT

$25.4M-15.8%

XencorXNCR

$736.85M-18.6%

AnaptysBio, Inc.ANAB

$329.68M-21.9%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's total assets?: Sutro Biopharma (STRO) reported total assets of $241.99M in Q1 2026.
How has Sutro Biopharma's total assets changed year-over-year?: Sutro Biopharma's total assets decreased by 24.7% year-over-year, from $321.43M to $241.99M.
What is the long-term trend for Sutro Biopharma's total assets?: Over 5 years (2020 to 2025), Sutro Biopharma's total assets has grown at a -15.1% compound annual growth rate (CAGR), from $394.11M to $173.83M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.